Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol Myers Squibb
Bristol Myers Squibb
BMS builds case for mavacamten label ahead of FDA decision
Pharmaforum
Thu, 02/17/22 - 11:01 am
Bristol Myers Squibb
mavacamten
obtructive hypertrophic cardiomyopathy
MyoKardia
FDA
The biggest launches of 2022: a reboot
EP Vantage
Mon, 02/14/22 - 10:48 am
drug launches
Eli Lilly
tirzepatide
Alnylam
vutrisiran
Roche
Vabysmo
JNJ
Carvykti
Mirati Therapeutics
adagrasib
Bristol Myers Squibb
mavacamten
deucravacitinib
Bristol Myers Squibb doles out $8M in new grants to improve health equity with cardiovascular, oncology focus
Fierce Biotech
Tue, 02/8/22 - 10:09 am
Bristol Myers Squibb
grants
health equity
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms
Fierce Pharma
Fri, 02/4/22 - 11:22 am
Bristol Myers Squibb
CAR-T
Breyanzi
Abecma
Not cheaper by the dozen: Bristol Myers becomes the 12th pharma company to restrict 340B sales
Endpoints
Tue, 01/25/22 - 11:43 pm
Bristol Myers Squibb
340B
What's Behind Bristol Myers Squibb's Latest Partnership?
Motley Fool
Sat, 01/22/22 - 02:17 pm
Bristol Myers Squibb
Century Therapeutics
CAR-T
cancer
Did BMS set up a subsidiary to avoid paying $1.4B in U.S. taxes? The Senate finance chairman is on the case
Fierce Pharma
Wed, 01/19/22 - 11:07 am
Bristol Myers Squibb
taxes
Senate
Biotech investors pray for a takeover miracle
EP Vantage
Fri, 01/14/22 - 11:09 am
M&A
biotech
Amylyx Pharmaceuticals
Arena Pharmaceuticals
AstraZeneca
Aurinia Pharmaceuticals
Biogen
Biohaven
Bristol Myers Squibb
Eli Lilly
GSK
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Prellis, Bristol Myers Squibb collaborate to discover antibodies
Pharmaceutical Business Review
Fri, 01/14/22 - 10:58 am
Prellis Biologics
Bristol Myers Squibb
antibodies
drug discovery
As Abecma sales take off, Bristol Myers and 2seventy scrap a follow-up CAR-T
Endpoints
Thu, 01/13/22 - 07:21 am
Bristol Myers Squibb
2seventy bio
Abecma
bb21217
CAR-T
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff
Fierce Pharma
Mon, 01/10/22 - 11:49 pm
JPMHC 2022
Bristol Myers Squibb
Revlimid
patent cliffs
Opdivo
Eliquis
Reblozyl
Breyanzi
#JPM22, Day 1: Bristol Myers Squibb's blockbuster losses of exclusivity, Novartis' spending plans and more
Fierce Pharma
Mon, 01/10/22 - 11:38 am
JPMHC 2022
Bristol Myers Squibb
Revlimid
Novartis
Moderna Therapeutics
JNJ
Trikafta
4 Biotechs That Were Winners at ASH
Motley Fool
Mon, 01/3/22 - 10:38 am
ASH2021
Bristol Myers Squibb
Agios Pharmaceuticals
Forma Therapeutics
Bluebird Bio
sickle cell disease
Multiple Myeloma
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Fierce Pharma
Fri, 12/31/21 - 11:10 am
patents
patent cliffs
Bristol Myers Squibb
Amgen
Pfizer
Revlimid
Eliquis
Enbrel
Otezla
Ibrance
Amgen builds Otezla’s psoriasis label as rival BMS looms large
Pharmaforum
Wed, 12/22/21 - 11:19 am
Amgen
Otezla
psoriasis
Bristol Myers Squibb
deucravacitinib
FDA delays its decision on Bristol Myers' $13B heart drug another three months
Endpoints
Fri, 12/17/21 - 11:18 am
Bristol Myers Squibb
mavacamten
ICER
FDA
Humana, Centene sue drugmakers, alleging anticompetitive practices on HIV drugs
BioPharma Dive
Thu, 12/16/21 - 10:45 am
Humana
Centene
generics
anticompetitive practices
Gilead Sciences
Bristol Myers Squibb
JNJ
Teva Pharmaceuticals
Bristol Myers drug wins first U.S. approval for Graft versus Host Disease prevention
Reuters
Wed, 12/15/21 - 11:54 pm
Bristol Myers Squibb
Orencia
FDA
graft vs host disease
Bristol Myers returns to Immatics for a dual-targeting cancer drug
BioPharma Dive
Tue, 12/14/21 - 11:10 am
Bristol Myers Squibb
Immatics
cancer
immunotherapy
Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan
Fierce Pharma
Tue, 12/14/21 - 10:43 am
Bristol Myers Squibb
Celgene
M&A
stock buybacks
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
next ›
last »